Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2017 | 1 |
2018 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye.
Pharmaceutics. 2021 Feb 5;13(2):219. doi: 10.3390/pharmaceutics13020219.
Pharmaceutics. 2021.
PMID: 33562561
Free PMC article.
Review.
Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection.
Puranen J, Koponen S, Nieminen T, Kanerva I, Kokki E, Toivanen P, Urtti A, Ylä-Herttuala S, Ruponen M.
Puranen J, et al. Among authors: kokki e.
Exp Eye Res. 2022 Nov;224:109237. doi: 10.1016/j.exer.2022.109237. Epub 2022 Sep 9.
Exp Eye Res. 2022.
PMID: 36096189
Free article.
Item in Clipboard
Human Vascular Endothelial Growth Factor A165 Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration.
Kokki E, Karttunen T, Olsson V, Kinnunen K, Ylä-Herttuala S.
Kokki E, et al.
Genes (Basel). 2018 Aug 31;9(9):438. doi: 10.3390/genes9090438.
Genes (Basel). 2018.
PMID: 30200369
Free PMC article.
Item in Clipboard
Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G, Kokki E, Alasaarela L, Lesch HP, Tuulos T, Kinnunen K, Uusitalo H, Airenne K, Yla-Herttuala S.
Kalesnykas G, et al. Among authors: kokki e.
Curr Gene Ther. 2017;17(3):235-247. doi: 10.2174/1566523217666171003170348.
Curr Gene Ther. 2017.
PMID: 28982327
Item in Clipboard
Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer.
Tuppurainen L, Sallinen H, Kokki E, Koponen J, Anttila M, Pulkkinen K, Heikura T, Toivanen P, Hämäläinen K, Kosma VM, Heinonen S, Alitalo K, Ylä-Herttuala S.
Tuppurainen L, et al. Among authors: kokki e.
Hum Gene Ther Clin Dev. 2013 Mar;24(1):29-37. doi: 10.1089/humc.2013.006. Epub 2013 Apr 3.
Hum Gene Ther Clin Dev. 2013.
PMID: 23692381
Item in Clipboard
Cite
Cite